Terms: = Head and neck cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
12 results:
1. The Function and Mechanism of Long Non-Coding RNA RP11-23J9.4 in Thyroid cancer.
Zhong L; Ding X; Xiong X; Hao T; Zhang C; Wang L; Zhao Y
Crit Rev Eukaryot Gene Expr; 2023; 33(4):53-61. PubMed ID: 37183946
[TBL] [Abstract] [Full Text] [Related]
2. Reiterative modeling of combined transcriptomic and proteomic features refines and improves the prediction of early recurrence in squamous cell carcinoma of head and neck.
Salehi A; Wang L; Coates PJ; Norberg Spaak L; Gu X; Sgaramella N; Nylander K
Comput Biol Med; 2022 Oct; 149():105991. PubMed ID: 36007290
[TBL] [Abstract] [Full Text] [Related]
3. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating axin2 through Wnt/β-catenin signaling pathway.
Lv P; Xue Y
Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
[TBL] [Abstract] [Full Text] [Related]
4. Phenome-Wide Scan Finds Potential Orofacial Risk Markers for cancer.
Bezamat M; Harrison B; Zhou Y; Glickman KM; Telles V; Guirguis C; Modesto A; Vieira AR
Sci Rep; 2020 Mar; 10(1):4869. PubMed ID: 32184411
[TBL] [Abstract] [Full Text] [Related]
5. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
Zhang LN; Zhao L; Yan XL; Huang YH
J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
[TBL] [Abstract] [Full Text] [Related]
6. Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
Mol Med Rep; 2015 Sep; 12(3):4352-4357. PubMed ID: 26081022
[TBL] [Abstract] [Full Text] [Related]
7. Wnt-C59 arrests stemness and suppresses growth of nasopharyngeal carcinoma in mice by inhibiting the Wnt pathway in the tumor microenvironment.
Cheng Y; Phoon YP; Jin X; Chong SY; Ip JC; Wong BW; Lung ML
Oncotarget; 2015 Jun; 6(16):14428-39. PubMed ID: 25980501
[TBL] [Abstract] [Full Text] [Related]
8. [Surgical treatment of tremendous neurogenic tumors in the root of neck].
Li J; Huang W; Chen J; Tang Z; Bao R
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Sep; 49(9):748-53. PubMed ID: 25487585
[TBL] [Abstract] [Full Text] [Related]
9. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.
Fu KK; Pajak TF; Marcial VA; Ortiz HG; Rotman M; Asbell SO; Coia LR; Vora NL; Byhardt R; Rubin P
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):577-88. PubMed ID: 7790242
[TBL] [Abstract] [Full Text] [Related]
10. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract] [Full Text] [Related]
11. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313.
Cox JD; Pajak TF; Marcial VA; Coia L; Mohiuddin M; Fu KK; Selim HM; Byhardt RW; Rubin P; Ortiz HG
Cancer; 1992 Jun; 69(11):2744-8. PubMed ID: 1571904
[TBL] [Abstract] [Full Text] [Related]
12. ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313.
Cox JD; Pajak TF; Marcial VA; Coia L; Mohiuddin M; Fu KK; Selim H; Rubin P; Ortiz H
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1191-5. PubMed ID: 2045293
[TBL] [Abstract] [Full Text] [Related]
